WaveLight EX500 Excimer Laser

WaveLight EX500 Excimer Laser

Alcon introduced its latest innovation in LASIK surgery technology, the WaveLight® EX500 excimer laser, during the 2012 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting in Chicago, Illinois. This is the first refractive surgery innovation that Alcon has unveiled since its merger with Novartis in April 2011. 'When Novartis acquired Alcon in 2011, we committed that our combined strength would provide additional benefits to our customers and their patients, delivering better services and bringing innovation to the market faster,' said Stuart Raetzman, area president, Alcon US. 'The new WaveLight EX500 excimer laser is the first refractive surgery innovation to be offered by the new Alcon. It provides enhanced customisation for our customers – saving time and delivering excellent refractive outcomes.'

www.alconsurgical.com

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...